Skip to main content
TipRanks
Go Ultimate75% OFF

International Stem Cell (ISCO) Financial Statements

45 Followers

International Stem Cell Financial Overview

International Stem Cell's market cap is currently $1.27M. The company's EPS TTM is $-0.06; its P/E ratio is -2.53; International Stem Cell has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Mar 25Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 9.10M$ 9.09M$ 7.79M$ 8.18M$ 7.18M
Gross Profit$ 5.07M$ 5.32M$ 4.61M$ 4.91M$ 4.24M
Operating Income$ -267.00K$ -68.00K$ -663.00K$ -196.00K$ -1.92M
EBITDA$ -48.00K$ 142.00K$ 202.00K$ 22.00K$ -509.00K
Net Income$ -418.00K$ -209.00K$ -131.00K$ -466.00K$ -1.04M
Balance Sheet
Cash & Short-Term Investments$ 993.00K$ 1.23M$ 1.59M$ 742.00K$ 171.00K
Total Assets$ 4.82M$ 5.17M$ 5.39M$ 5.13M$ 4.95M
Total Debt$ 3.73M$ 3.84M$ 4.18M$ 4.28M$ 4.07M
Net Debt$ 2.74M$ 2.61M$ 2.59M$ 3.53M$ 3.90M
Total Liabilities$ 8.88M$ 9.10M$ 5.28M$ 9.65M$ 9.53M
Stockholders' Equity$ -4.06M$ -3.93M$ 113.00K$ -4.52M$ -4.59M
Cash Flow
Free Cash Flow$ -35.00K$ -153.00K$ 846.00K$ 321.00K$ -1.34M
Operating Cash Flow$ 8.00K$ 13.00K$ 929.00K$ 332.00K$ -1.30M
Investing Cash Flow$ -45.00K$ -171.00K$ -83.00K$ -11.00K$ -45.00K
Financing Cash Flow$ -200.00K$ -200.00K$ 0.00$ 250.00K$ 824.00K

Currency in USD

International Stem Cell Earnings and Revenue History

-8M08M16M-90 %-60 %-30 %0 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

International Stem Cell Liabilities to Assets

04M8M12M50 %100 %150 %200 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

International Stem Cell Cash Flow

-3M-2M-1M01M2M3M4M201720182019202020212022202320242025OperatingInvestingFinancing

International Stem Cell Forecast EPS vs Actual EPS

-0.1-0.10000Q4 22Q1 23Q4 23Q1 24Q4 24EPS EstimateBeatMiss